Terms: = Kidney tumors AND SEPT5, HCDCREL-1, 5413, ENSG00000184702, Q99719, PNUTL1, H5
4 results:
1. B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells.
Emaldi M; Nunes-Xavier CE
Cells; 2022 Apr; 11(9):. PubMed ID: 35563753
[TBL] [Abstract] [Full Text] [Related]
2. Reassessing the cost-effectiveness of nivolumab for the treatment of renal cell carcinoma based on mature survival data, updated safety and lower comparator price.
Kim H; Goodall S; Liew D
J Med Econ; 2021; 24(1):893-899. PubMed ID: 34259119
[No Abstract] [Full Text] [Related]
3. Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein.
Janakiram M; Chinai JM; Fineberg S; Fiser A; Montagna C; Medavarapu R; Castano E; Jeon H; Ohaegbulam KC; Zhao R; Zhao A; Almo SC; Sparano JA; Zang X
Clin Cancer Res; 2015 May; 21(10):2359-66. PubMed ID: 25549724
[TBL] [Abstract] [Full Text] [Related]
4. Effect of hepatocyte growth factor/scatter factor and other growth factors on motility and morphology of non-tumorigenic and tumor cells.
Li Y; Bhargava MM; Joseph A; Jin L; Rosen EM; Goldberg ID
In Vitro Cell Dev Biol Anim; 1994 Feb; 30A(2):105-10. PubMed ID: 7516797
[TBL] [Abstract] [Full Text] [Related]
